Federated Hermes reports 17.17% stake in Minerva (NASDAQ: NERV)

Rhea-AI Filing Summary

Federated Hermes, Inc. filed Amendment No. 1 to a Schedule 13G/A reporting ownership of 8,690,926 shares of Minerva Neurosciences, Inc. common stock, representing 17.17% of the class as shown on the cover pages (date noted: 06/30/2026). The amendment lists related reporting persons including the Voting Shares Irrevocable Trust and Thomas R., Ann C., and J. Christopher Donahue and includes a Rule 13d-4 disclaimer that they do not admit beneficial ownership of securities held by managed funds.

Insights

Institutional Ownership Analyst

Federated Hermes reports a large, disclosed passive stake.

The filing shows 8,690,926 shares (17.17%) of common stock on the cover pages dated 06/30/2026, a position reported via a Schedule 13G/A amendment. The filing structure and Rule 13d-4 language indicate reporting for managed funds and related persons rather than an assertion of personal beneficial ownership.

Future disclosures or additional amendments could clarify whether the position is passive or active; cash-flow treatment and any plans for disposition are not included in the provided excerpt.

Corporate Governance Expert

Related trustees and the parent entity are listed with shared voting/dispositive power.

The cover responses show shared voting and dispositive power of 8,690,926 shares attributed across Federated Hermes, the Voting Shares Irrevocable Trust, and named trustees. The filing includes an exhibit list for joint-filing agreement and power of attorney, standard for coordinated reporting.

Investors should note the Rule 13d-4 disclaimer in the filing; subsequent exhibits or filings would prove who holds control or whether voting arrangements change.

Key Figures

Filing type: Schedule 13G/A (Amendment No. 1) Shares reported: 8,690,926 shares Percent of class: 17.17% +2 more

5 metrics

Filing type Schedule 13G/A (Amendment No. 1) cover pages dated 06/30/2026

Shares reported 8,690,926 shares amount shown on cover pages

Percent of class 17.17% percent shown on cover pages

CUSIP 603380205 Minerva Neurosciences common stock

Related reporting persons Voting Shares Irrevocable Trust; Thomas R., Ann C., J. Christopher Donahue listed alongside Federated Hermes on amendment

Key Terms

Schedule 13G/A, Rule 13d-4, beneficial ownership

3 terms

Schedule 13G/A regulatory

"Amendment No. 1 to a Schedule 13G/A reporting ownership"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Rule 13d-4 regulatory

"In accordance with Rule 13d-4 under the Exchange Act"

beneficial ownership financial

"expressly disclaim beneficial ownership of such securities"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/08/2026 - 07:52 AM Accepted by SEC EDGAR 07/08/2026 - 07:51 AM Learn about SEC filing dates

FAQ

What stake does Federated Hermes report in Minerva Neurosciences (NERV)?

Federated Hermes reports ownership of 8,690,926 shares, stated as 17.17% of the common stock on the cover pages, with the cover date 06/30/2026. The filing is an Amendment No. 1 to a Schedule 13G/A listing related reporting persons.

Does the Schedule 13G/A say Federated Hermes is the beneficial owner?

The filing includes a specific Rule 13d-4 disclaimer: Federated Hermes, the Voting Shares Irrevocable Trust, and the named Donahues expressly disclaim beneficial ownership of securities held by managed funds, as stated in the comment language.

Who else is named on the filing besides Federated Hermes?

The amendment names the Voting Shares Irrevocable Trust and individuals Thomas R. Donahue, Ann C. Donahue, and J. Christopher Donahue, each shown with shared voting and dispositive power over the 8,690,926 shares reported on the cover pages.

What supporting exhibits are attached to this Schedule 13G/A amendment?

The filing references exhibits including an Item 3 classification of reporting persons, an agreement for joint filing and a power of attorney (Exhibits 1–3), as listed in the Exhibit Information section of the amendment.

What voting and dispositive powers are reported for the position?

Cover-page responses show sole voting/dispositive power of 8,690,926 for Federated Hermes in one entry and shared voting/dispositive power of 8,690,926 for the Trust and individual trustees in other entries, each tied to the same 8,690,926-share figure and 17.17% percent.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Minerva Neurosciences, Inc.

(Name of Issuer)

COMMON STOCK

(Title of Class of Securities)

603380205

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 603380205

1

Names of Reporting Persons

Federated Hermes, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

PENNSYLVANIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 8,690,926.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 8,690,926.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

8,690,926.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

17.17 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

CUSIP Number(s): 603380205

1

Names of Reporting Persons

Voting Shares Irrevocable Trust

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

PENNSYLVANIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 8,690,926.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 8,690,926.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

8,690,926.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

17.17 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: In accordance with Rule 13d-4 under the Exchange Act, Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue declare that this report should not be construed as an admission that any of them is the beneficial owner of the securities held by any of the Managed Funds, and each of Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue expressly disclaim beneficial ownership of such securities.

SCHEDULE 13G

CUSIP Number(s): 603380205

1

Names of Reporting Persons

Thomas R. Donahue

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 8,690,926.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 8,690,926.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

8,690,926.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

17.17 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: In accordance with Rule 13d-4 under the Exchange Act, Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue declare that this report should not be construed as an admission that any of them is the beneficial owner of the securities held by any of the Managed Funds, and each of Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue expressly disclaim beneficial ownership of such securities.

SCHEDULE 13G

CUSIP Number(s): 603380205

1

Names of Reporting Persons

Ann C. Donahue

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 8,690,926.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 8,690,926.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

8,690,926.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

17.17 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: In accordance with Rule 13d-4 under the Exchange Act, Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue declare that this report should not be construed as an admission that any of them is the beneficial owner of the securities held by any of the Managed Funds, and each of Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue expressly disclaim beneficial ownership of such securities.

SCHEDULE 13G

CUSIP Number(s): 603380205

1

Names of Reporting Persons

J. Christopher Donahue

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 8,690,926.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 8,690,926.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

8,690,926.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

17.17 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: In accordance with Rule 13d-4 under the Exchange Act, Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue declare that this report should not be construed as an admission that any of them is the beneficial owner of the securities held by any of the Managed Funds, and each of Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue expressly disclaim beneficial ownership of such securities.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Minerva Neurosciences, Inc.
(b)	Address of issuer's principal executive offices: 1500 District Avenue, Burlington, MA 01803
Item 2.
(a)	Name of person filing: Federated Hermes, Inc.
(b)	Address or principal business office or, if none, residence: 1001 Liberty Avenue, Pittsburgh, PA 15222-3779
(c)	Citizenship: Pennsylvania
(d)	Title of class of securities: COMMON STOCK
(e)	CUSIP No.: 603380205
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See response to Item 9 on each cover page.
(b)	Percent of class: See response to Item 11 on each cover page.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See response to Item 5 on each cover page.
	(ii) Shared power to vote or to direct the vote: See response to Item 6 on each cover page.
	(iii) Sole power to dispose or to direct the disposition of: See response to Item 7 on each cover page.
	(iv) Shared power to dispose or to direct the disposition of: See response to Item 8 on each cover page.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See Exhibit "1" Attached
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Federated Hermes, Inc.

Signature:	/s/J. Christopher Donahue
Name/Title:	J. Christopher Donahue, as President of Federated Hermes, Inc.
Date:	07/08/2026

Voting Shares Irrevocable Trust

Signature:	/s/Thomas R. Donahue
Name/Title:	Thomas R. Donahue, as Trustee of Voting Shares Irrevocable Trust
Date:	07/08/2026

Signature:	/s/Ann C. Donahue
Name/Title:	Ann C. Donahue, as Trustee of Voting Shares Irrevocable Trust
Date:	07/08/2026

Signature:	/s/J. Christopher Donahue
Name/Title:	J. Christopher Donahue, as Trustee of Voting Shares Irrevocable Trust
Date:	07/08/2026

Thomas R. Donahue

Signature:	/s/Thomas R. Donahue
Name/Title:	Thomas R. Donahue
Date:	07/08/2026

Ann C. Donahue

Signature:	/s/Ann C. Donahue
Name/Title:	Ann C. Donahue
Date:	07/08/2026

J. Christopher Donahue

Signature:	/s/J. Christopher Donahue
Name/Title:	J. Christopher Donahue
Date:	07/08/2026

Comments accompanying signature: SEE EXHIBITS 2 AND 3 ATTACHED Exhibit Information EXHIBIT 1 ITEM 3 CLASSIFICATION OF REPORTING PERSONS EXHIBIT 2 AGREEMENT FOR JOINT FILING OF SCHEDULE 13G EXHIBIT 3 POWER OF ATTORNEY